Baseline FEV1 Predicts Response to Biologic Treatment in Severe Asthma

被引：0
作者：
Huang, Y. F. [1 ]
Denby, G. [1 ]
Bajwa, R. [1 ]
Hakim, R. [1 ]
Masel, P. [1 ]
机构：
[1] Prince Charles Hosp, Thorac Dept, Brisbane, Qld, Australia
来源：
RESPIROLOGY | 2022年 / 27卷
关键词：
FEV1; ACQ; Asthma; Omalizumab; Benralizumab; Mepolizumab; ALLERGIC-ASTHMA; OMALIZUMAB;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AP 003
引用
收藏
页码：15 / 15
页数：1
相关论文
共 4 条
[1]   Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study [J].
Casale, Thomas B. ;
Luskin, Allan T. ;
Busse, William ;
Zeiger, Robert S. ;
Trzaskoma, Benjamin ;
Yang, Ming ;
Griffin, Noelle M. ;
Chipps, Bradley E. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (01) :156-+
[2]   Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies [J].
FitzGerald, J. Mark ;
Bleecker, Eugene R. ;
Menzies-Gow, Andrew ;
Zangrilli, James G. ;
Hirsch, Ian ;
Metcalfe, Paul ;
Newbold, Paul ;
Goldman, Mitchell .
LANCET RESPIRATORY MEDICINE, 2018, 6 (01) :51-64
[3]   Exploring the Effects of Omalizumab in Allergic Asthma An Analysis of Biomarkers in the EXTRA Study [J].
Hanania, Nicola A. ;
Wenzel, Sally ;
Rosen, Karin ;
Hsieh, Hsin-Ju ;
Mosesova, Sofia ;
Choy, David F. ;
Lal, Preeti ;
Arron, Joseph R. ;
Harris, Jeffrey M. ;
Busse, William .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187 (08) :804-811
[4]   Predictors of response to therapy with omalizumab in patients with severe allergic asthma - a real life study [J].
Kallieri, Maria ;
Papaioannou, Andriana I. ;
Papathanasiou, Evgenia ;
Ntontsi, Polyxeni ;
Papiris, Spyridon ;
Loukides, Stelios .
POSTGRADUATE MEDICINE, 2017, 129 (06) :598-604
1